Cargando…
Targeting the Vasoprotective Axis of the Renin-Angiotensin System: A Novel Strategic Approach to Pulmonary Hypertensive Therapy
A decade has passed since the discovery of angiotensin-converting enzyme 2 (ACE2), a component of the ACE2–angiotensin (Ang)-(1-7)–Mas counterregulatory axis of the renin angiotensin system (RAS). ACE2 is considered an endogenous regulator of the vasoconstrictive, proliferative, fibrotic, and proinf...
Autores principales: | Bradford, Chastity N., Ely, Debra R., Raizada, Mohan K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957877/ https://www.ncbi.nlm.nih.gov/pubmed/20556668 http://dx.doi.org/10.1007/s11906-010-0122-6 |
Ejemplares similares
-
Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Receptor Axis: Emerging Pharmacological Target for Pulmonary Diseases
por: Shenoy, Vinayak, et al.
Publicado: (2015) -
Some Aspects of the Renin-Angiotensin- System in Hemodialysis Patients
por: Malik, Umar, et al.
Publicado: (2015) -
Therapeutic Approaches to the Alternative Angiotensin-(1–7) Axis of the Renin-Angiotensin System
por: Chappell, Mark C
Publicado: (2017) -
Renin-Angiotensin Aldosterone System and Hypertension: Current Approaches and Future Directions
por: Flack, John M., et al.
Publicado: (2007) -
Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure
por: Arendse, Lauren B., et al.
Publicado: (2019)